Leanne M. Gauld
Brisbane, QLD, Australia
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 10 publications
Differential respiratory function response in paediatric spinal muscular atrophy types 2 and 3 treated with nusinersen over 3 years.
Journal: Sleep medicine
Published: October 22, 2024
Persistent Pseudomonas aeruginosa infection associated with non-invasive ventilation in a child with spinal muscular atrophy type 1.
Journal: Journal of clinical sleep medicine : JCSM : official publication of the American Academy of Sleep Medicine
Published: November 18, 2020
Effect of nusinersen on respiratory function in paediatric spinal muscular atrophy types 1-3.
Journal: Thorax
Published: November 12, 2020
Limited Assessment of Respiratory Muscle Response to Nusinersen Treatment in Infants with Spinal Muscular Atrophy.
Journal: American journal of respiratory and critical care medicine
Published: November 21, 2019
Early NIV is associated with accelerated lung function decline in Duchenne muscular dystrophy treated with glucocorticosteroids.
Journal: BMJ open respiratory research
Published: October 20, 2019
Polysomnography findings in pediatric spinal muscular atrophy types 1-3.
Journal: Sleep medicine
Published: August 27, 2019
Relationship between respiratory function and need for NIV in childhood SMA.
Journal: Pediatric pulmonology
Published: March 02, 2019
Showing 1-10 of 10
Last Updated: 09/26/2026